About the Speaker
Dr. David Barzilai is a globally recognized longevity physician and keynote speaker, CEO of Barzilai Longevity Consulting and founding faculty member of the Geneva College of Longevity Science.
He serves as a lecturer at Harvard Medical School, holds dual doctorates (MD/PhD), and is board-certified in lifestyle medicine as a Diplomat of the American Board of Lifestyle Medicine (DipABLM)
A frequent keynote speaker at major scientific and medical conferences, Dr. Barzilai is known for translating cutting-edge research into practical, high-impact interventions.
Through Agingdoc.com, he delivers personalized, evidence-based longevity consultations to individuals and institutions, integrating advanced scientific and clinical insights to extend and optimize healthspan.
To connect with Dr. Barzilai as a keynote speaker, scientific and business strategy advisory board member, or consultant in longevity medicine and evidence-based practices, visit his LinkedIn profile: linkedin.com/in/agingdoc
Speaking Topics
In his presentations, Dr. Barzilai explores:
-
The longevity landscape: Where we are headed, challenges and opportunities
-
Decoding Longevity Medicine: What It Is—and Why it Matters
-
The Power of Precision Health: A Proactive Approach to Predicting and Preventing Disease
-
Why we age — and what we can do: An evidence-driven exploration of validated strategies to slow biological aging and extend healthspan.
-
The future of healthcare and therapeutics: How precision screening, AI-enabled early detection, targeted interventions, and prevention-first models are redefining medicine.
-
Lifestyle medicine for healthy aging: Nutrition, movement, sleep, stress physiology, and emotional wellbeing — distilled into actionable daily practices
-
Longevity Best Practices: practical frameworks for clinicians, leaders, businesses, and everyday optimizers
-
A balanced, evidence-driven evaluation of leading longevity interventions — including pharmacologic options (such as GLP-1 receptor agonists like Ozempic, metformin, and rapamycin), senolytics, peptides, regenerative and genetic therapies, hyperbaric oxygen therapy, thermal and cold exposure, blood-based rejuvenation strategies, microplastics and other environmental risk factors, nutraceuticals, supplements, lifestyle protocols, and additional science-supported approaches to extending healthspan.
Audiences & Formats
Each engagement is tailored to the audience — from clinicians and scientists seeking rigor, to entrepreneurs and investors looking for insight, to general audiences eager to understand and apply longevity principles.
Exploring the Longevity Landscape
The field of longevity is moving from vision to reality. Breakthroughs in precision diagnostics, AI-enabled medicine, and translational therapeutics are expanding what’s possible — while advances in preventive and lifestyle medicine are making healthspan extension achievable at scale.
My work focuses on helping audiences navigate this transformation:
What longevity medicine really is — and what it’s not
How longevity science is reshaping healthcare, business, and daily life
What best practices can guide responsible innovation and adoption
How we can scale healthspan for all, not just for the few
Recent and upcoming engagements include keynote addresses, panels, and presentations at:
What Audiences Gain
-
A grounded understanding of the longevity ecosystem — from science to society
-
Clear, evidence-based insights into longevity and precision medicine
-
Frameworks for scaling healthspan across individuals and institutions
-
Practical longevity best practices for performance, resilience, and wellbeing
-
A forward-looking view of how the future of medicine is being rewritten now
For Organizers
A grounded understanding of the longevity ecosystem — from science to society
Clear, evidence-based insights into longevity and precision medicine
Frameworks for scaling healthspan across individuals and institutions
Practical longevity best practices for performance, resilience, and wellbeing
A forward-looking view of how the future of medicine is being rewritten now
